Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
343
-
Total 13F shares, excl. options
-
43M
-
Shares change
-
+994K
-
Total reported value, excl. options
-
$6.53B
-
Value change
-
+$196M
-
Put/Call ratio
-
0.38
-
Number of buys
-
151
-
Number of sells
-
-174
-
Price
-
$151.79
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2020
403 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q4 2020.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 343 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43M shares
of 44.8M outstanding shares and own 95.95% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.27M shares), VANGUARD GROUP INC (3.96M shares), RENAISSANCE TECHNOLOGIES LLC (3.61M shares), Avoro Capital Advisors LLC (2.85M shares), FMR LLC (2.32M shares), STATE STREET CORP (1.54M shares), ACADIAN ASSET MANAGEMENT LLC (1.13M shares), DIMENSIONAL FUND ADVISORS LP (886K shares), FIRST TRUST ADVISORS LP (847K shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (825K shares).
This table shows the top 343 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.